Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from LifeVantage ( (LFVN) ) is now available.
LifeVantage Corporation held its fiscal year 2026 annual meeting of stockholders on November 6, 2025, where 75.41% of the company’s common stock was represented. During the meeting, stockholders elected seven directors to the board, approved executive compensation on an advisory basis, ratified Deloitte & Touche as the independent accounting firm, and approved an amendment to the 2017 Long-Term Incentive Plan.
The most recent analyst rating on (LFVN) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on LifeVantage stock, see the LFVN Stock Forecast page.
Spark’s Take on LFVN Stock
According to Spark, TipRanks’ AI Analyst, LFVN is a Neutral.
LifeVantage’s overall stock score reflects a mix of strong financial performance and attractive valuation, offset by bearish technical indicators and some operational challenges highlighted in the earnings call. The company’s strategic initiatives, particularly in the gut health market, provide a positive outlook, but maintaining operational efficiency and addressing cost pressures will be key to future success.
To see Spark’s full report on LFVN stock, click here.
More about LifeVantage
Average Trading Volume: 161,889
Technical Sentiment Signal: Sell
Current Market Cap: $92.21M
For a thorough assessment of LFVN stock, go to TipRanks’ Stock Analysis page.